Skip to content

Lidoment - pain osteomioarticular - phase IV

Lidoment, analgesic medicamental formulation for relief of the pain in the system osteomioarticular.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
RPCEC
Registry ID
RPCEC00000094
Enrollment
200
Registered
2010-03-01
Start date
2007-06-30
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Daily topical application of the analgesic gel, during 7 days. The formulation contains the mixture of Lidocaine 5% - 30 ml and Menthol 1%.

Sponsors

Municipality of Public Health, Plaza.
Lead Sponsor
Ministry of Public Health. Cuba.
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patient of any age, sex and ethnic group that are remitted by the specialist in Anesthesiology, of the service of integral Rehabilitation of the Vedado Policlinical, payees of pains osteomioarticulars, which were remitted to their consultation to be valued and treaties. 2.The patients' consent to participate in the trial, included in the pattern of clinical history of the pain made for the same ones.

Exclusion criteria

Exclusion criteria: a.Patients that presented some pathology like: sepsis in the affected area, oncological processes, bigger psychiatric dysfunctions and/or cerebral damage. b.The negative of the patients of participating in the investigation.

Design outcomes

Primary

MeasureTime frame
Pain (analogue pain scale,0-10, 0 is no pain and 10 is the worst imaginable pain). Measurement time: Daily by the patient, 7 days after begining the treatment by the doctor.

Secondary

MeasureTime frame
Osteomioarticular system lesions (description of lesions). Measurement time: 7 days after begining the treatment.

Countries

Cuba

Contacts

Public ContactMalena Zelada Pérez

Vedado Policlinical

mzelada@infomed.sld.cu

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Aug 15, 2026